Twist Bioscience Corp reports results for the quarter ended in December - Earnings Summary

Twist Bioscience

03/02/2023 14:31

* Twist Bioscience Corp  TWST.OQ  reported a quarterly
adjusted
loss of 74 cents​​ per share for the quarter ended in December.
The mean expectation of seven analysts for the quarter was for a
loss of $1.13 per share.
    * Revenue rose 29.1% to $54.24 million from a year ago;
analysts
expected $54.10 million. 
    * Twist Bioscience Corp's reported EPS for the quarter was a
loss
of 74 cents​.
    * The mean earnings estimate of analysts had risen by
about 2.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Twist Bioscience Corp shares had risen by 29.8% this
quarter.
    * The company reported a quarterly loss of $41.82 million.
    * Wall Street's median 12-month price target for Twist
Bioscience
Corp is $36.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
3 at 02:31 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -1.13          -0.74          Beat
 Sep. 30 2022      -1.25          -0.91          Beat
 Jun. 30 2022      -1.31          -1.08          Beat
 Mar. 31 2022      -1.28          -1.13          Beat